Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus.

Eur Respir Rev

Division of Rheumatology, Dept of Medicine, University Health Network, Mount Sinai Hospital and University of Toronto, ON, Canada.

Published: December 2011

Pulmonary arterial hypertension (PAH) is a severe manifestation of systemic sclerosis (SSc) and systemic lupus erythematosus (SLE). Due to improvements in the understanding of the pathogenesis of these diseases, improved methodological rigour in the conduct of epidemiological studies and the advent of successful therapies, our understanding of SSc-PAH and SLE-PAH has evolved considerably. In this review we will review the current evidence regarding the prevalence, prognostic factors and survival estimates for SSc-PAH and SLE-PAH. In doing so, we will compare and contrast these two diseases, highlight clinically useful features, discuss methodological limitations of existing data, and draw attention to areas where research is needed.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487746PMC
http://dx.doi.org/10.1183/09059180.00003811DOI Listing

Publication Analysis

Top Keywords

systemic sclerosis
8
systemic lupus
8
lupus erythematosus
8
ssc-pah sle-pah
8
pulmonary hypertension
4
systemic
4
hypertension systemic
4
sclerosis systemic
4
erythematosus pulmonary
4
pulmonary arterial
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!